PMID- 12851692 OWN - NLM STAT- MEDLINE DCOM- 20040304 LR - 20061115 IS - 1019-6439 (Print) IS - 1019-6439 (Linking) VI - 23 IP - 2 DP - 2003 Aug TI - Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia. PG - 429-36 AB - Tumor necrosis factor-alpha (TNF-alpha) and interleukin 6 (IL-6) are important mediators in cancer cachexia; however, the expression of these cytokines and their receptors in tumor-bearing animals is poorly characterized. We analyzed expression of TNF-alpha, IL-6, tumor necrosis factor (TNF-RI, TNF-RII) and interleukin 6 (IL-6R) receptors in the brain, kidney, spleen, liver, muscle, ascite tumors and serum, from Yoshida AH-130 hepatoma-bearing rats. TNF-alpha increased in the brain, spleen, liver, and muscle of cachectic animals; IL-6 increased in the liver and muscle. AH-130 cells expressed a good level of TNF-alpha; on the contrary, no TNF-alpha or IL-6 protein was detected in the serum of either tumor-bearing or control animals. TNF-RI mRNA was up-regulated in the spleen, liver and muscle of tumor-bearing rats. TNF-RI protein levels confirmed up-regulation in the spleen and liver, but failed to detect any increase in the muscle. Western blotting against TNF-RI revealed two bands of lower molecular weight in cachectic muscle, suggesting proteolysis involving TNF-RI. No significant increase of either TNF-RII or IL-6R was observed. This is the first demonstration of a selective up-regulation of TNF-RI in cancer cachexia and suggests that local production of TNF-alpha and IL-6 is a corner-stone in the induction/maintenance of this syndrome. FAU - Catalano, Maria G AU - Catalano MG AD - Laboratorio di Endocrinologia Oncologica, Dipartimenti di Fisiopatologia Clinica and Oncologia, Universita di Torino, I-10126 Turin, Italy. FAU - Fortunati, Nicoletta AU - Fortunati N FAU - Arena, Katia AU - Arena K FAU - Costelli, Paola AU - Costelli P FAU - Aragno, Manuela AU - Aragno M FAU - Danni, Oliviero AU - Danni O FAU - Boccuzzi, Giuseppe AU - Boccuzzi G LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Greece TA - Int J Oncol JT - International journal of oncology JID - 9306042 RN - 0 (Antigens, CD) RN - 0 (Interleukin-6) RN - 0 (RNA, Messenger) RN - 0 (RNA, Neoplasm) RN - 0 (Receptors, Interleukin-7) RN - 0 (Receptors, Tumor Necrosis Factor) RN - 0 (Receptors, Tumor Necrosis Factor, Type I) RN - 0 (Receptors, Tumor Necrosis Factor, Type II) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Animals MH - Antigens, CD/genetics/*metabolism MH - Cachexia/etiology/*metabolism MH - Interleukin-6/metabolism MH - Male MH - Neoplasms, Experimental/complications/*metabolism/pathology MH - RNA, Messenger/genetics MH - RNA, Neoplasm/genetics MH - Rats MH - Receptors, Interleukin-7/metabolism MH - Receptors, Tumor Necrosis Factor/genetics/*metabolism MH - Receptors, Tumor Necrosis Factor, Type I MH - Receptors, Tumor Necrosis Factor, Type II MH - Reverse Transcriptase Polymerase Chain Reaction MH - Tissue Distribution MH - Tumor Necrosis Factor-alpha/metabolism MH - Up-Regulation EDAT- 2003/07/10 05:00 MHDA- 2004/03/05 05:00 CRDT- 2003/07/10 05:00 PHST- 2003/07/10 05:00 [pubmed] PHST- 2004/03/05 05:00 [medline] PHST- 2003/07/10 05:00 [entrez] PST - ppublish SO - Int J Oncol. 2003 Aug;23(2):429-36.